Fisher & Paykel Healthcare C: Market Snapshot and Recent Cyber‑Security Incident
During the 24‑hour trading window that closed at 08:58 PM Central Europe on Thursday, 22 October 2026, shares of Fisher & Paykel Healthcare Corp Ltd (FPH.AX) declined modestly by 0.1 %. At the close, the stock traded at approximately AUD 39.63, a level that reflects a 10.11 % rally since the end of the previous month.
Trading Metrics
| Item | Value |
|---|---|
| Current price | AUD 39.63 |
| Market cap | AUD 23.2 bn |
| 24‑hour volume | AUD 16.2 mn |
| Shares outstanding | 588.3 mn |
| 200‑day SMA | AUD 33.1 |
| 52‑week high | AUD 40.15 (21 Oct 2026) |
| 52‑week low | AUD 26.51 (15 May 2026) |
The recent price dip is statistically insignificant within the context of the stock’s longer‑term trend. The 200‑day simple moving average sits well below the current price, indicating a continued bullish bias among technical analysts.
Cyber‑Security Breach Disclosure
On 22 October 2026, Fisher & Paykel Healthcare announced that it had identified unauthorized access to two employee e‑mail accounts and a limited set of corporate files. Management’s rapid response included containment measures, an internal investigation, and notification of the affected individuals and relevant regulatory bodies.
Key points from the announcement:
- Containment and Scope – The breach was isolated to employee accounts and non‑clinical file sets; no evidence suggests that systems storing patient data were compromised.
- Operational Impact – Manufacturing, supply chain, and customer‑support operations remained uninterrupted.
- Malware Assessment – Management confirmed the absence of ransomware or other malware.
- Financial Outlook – The incident is deemed contained, with no expected material impact on financial performance.
The disclosure prompted a modest decline in share price, but the company’s emphasis on the continued integrity of its core business and global product distribution helped temper broader market concerns.
Comparative Stock Activity
The performance of several peer securities over the same 24‑hour period provides context for Fisher & Paykel’s market reaction.
| Stock | Ticker | 24‑h Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| Auckland Airport | AIA.AX | +0.61 % | AUD 6.74 | AUD 11.3 bn | 41.59 |
| Vector | VQA.F | 0 % | EUR 2.16 | EUR 2.2 bn | 32.46 |
| A2 Milk | A2M.AX | –1.16 % | AUD 6.91 | AUD 4.9 bn | 28.61 |
| Infratil | IFT.AX | +1.94 % | AUD 9.92 | AUD 9.8 bn | 45.32 |
| Meridian Energy | MEZ.AX | –1.12 % | AUD 4.59 | AUD 11.8 bn | 112.57 |
While Fisher & Paykel’s decline was modest, the broader market displayed a mixed picture, with some peers gaining momentum and others experiencing similar or larger downturns.
Company Profile
Fisher & Paykel Healthcare Corp Ltd is a New Zealand‑based health‑care equipment manufacturer listed on the ASX All Markets. Founded in 2001, the firm specializes in heated humidification systems for respiratory care, sleep‑apnea treatment, patient warming, and neonatal care products. The company’s product portfolio is distributed globally, and it maintains a strong focus on research and development to drive innovation in respiratory and neonatal technologies.
For further information on product offerings and corporate disclosures, stakeholders can visit the company’s website at www.fphcare.co.nz .
